⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iii squamous cell carcinoma of the oropharynx

Every month we try and update this database with for stage iii squamous cell carcinoma of the oropharynx cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerNCT00003809
Head and Neck C...
cetuximab
cisplatin
18 Years - 120 YearsEastern Cooperative Oncology Group
Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00033449
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
gefitinib
radiation thera...
cisplatin
laboratory biom...
18 Years - National Cancer Institute (NCI)
Biomarkers in Patients With Head and Neck CancerNCT01466257
Head and Neck C...
cetuximab
cisplatin
DNA analysis
gene expression...
mutation analys...
laboratory biom...
18 Years - 120 YearsEastern Cooperative Oncology Group
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsNCT00006036
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 YearsCanadian Cancer Trials Group
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionNCT00002901
Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck CancerNCT00004917
Anemia
Head and Neck C...
epoetin alfa
cisplatin
radiation thera...
18 Years - Radiation Therapy Oncology Group
Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00281840
Head and Neck C...
bevacizumab
docetaxel
conventional su...
radiation thera...
18 Years - Case Comprehensive Cancer Center
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and NeckNCT00084318
Head and Neck C...
cetuximab
cisplatin
docetaxel
radiation thera...
18 Years - Radiation Therapy Oncology Group
PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By SurgeryNCT00276523
Head and Neck C...
PEG-interferon ...
Conventional su...
Neoadjuvant the...
18 Years - M.D. Anderson Cancer Center
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the OropharynxNCT00899340
Head and Neck C...
gene expression...
microarray anal...
protein express...
immunohistochem...
laboratory biom...
- Vanderbilt-Ingram Cancer Center
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerNCT02177838
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey
Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck CancerNCT00002654
Head and Neck C...
chemotherapy
cisplatin
low-LET cobalt-...
low-LET electro...
low-LET photon ...
20 Years - 75 YearsSwiss Group for Clinical Cancer Research
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerNCT00003888
Head and Neck C...
cisplatin
docetaxel
fluorouracil
radiation thera...
18 Years - 70 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00006107
Head and Neck C...
Taxotere
Surgery
radiation thera...
18 Years - Dana-Farber Cancer Institute
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerNCT00023959
Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
hydroxyurea
fluorouracil
bevacizumab
radiation thera...
filgrastim
laboratory biom...
18 Years - National Cancer Institute (NCI)
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or HypopharynxNCT00757549
Head and Neck C...
cetuximab
cisplatin
TdT-mediated dU...
3'-deoxy-3'-[18...
immunohistochem...
laboratory biom...
fludeoxyglucose...
radiation thera...
18 Years - 120 YearsMayo Clinic
Germline Mutations in Patients With Head and Neck Cancer and a Family History of CancerNCT00482872
Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 YearsVanderbilt University Medical Center
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck CancerNCT00068237
Head and Neck C...
Radiation Toxic...
Xerostomia
salivary gland ...
Post-operative ...
18 Years - Radiation Therapy Oncology Group
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerNCT00963326
Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI)
Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck CancerNCT00720083
Head and Neck C...
cisplatin
vandetanib
radiation thera...
18 Years - Radiation Therapy Oncology Group
Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00114153
Head and Neck C...
capecitabine
carboplatin
conventional su...
radiation thera...
18 Years - National Cancer Institute (NCI)
Oxaliplatin in Treating Patients With Advanced Head and Neck CancerNCT00005035
Head and Neck C...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx CancerNCT00014118
Head and Neck C...
carboplatin
paclitaxel
conventional su...
radiation thera...
18 Years - 120 YearsEastern Cooperative Oncology Group
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal CancerNCT00006360
Head and Neck C...
Radiation Toxic...
radioprotection
radiation thera...
18 Years - 120 YearsRadiation Therapy Oncology Group
DNA Analysis of Tissue Samples From Patients With Head and Neck CancerNCT00898664
Head and Neck C...
cytogenetic ana...
gene expression...
mutation analys...
polymerase chai...
immunohistochem...
laboratory biom...
18 Years - Vanderbilt-Ingram Cancer Center
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00352118
Head and Neck C...
filgrastim
pegfilgrastim
cisplatin
docetaxel
fluorouracil
conventional su...
radiation thera...
18 Years - Masonic Cancer Center, University of Minnesota
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionNCT00002901
Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the OropharynxNCT00899340
Head and Neck C...
gene expression...
microarray anal...
protein express...
immunohistochem...
laboratory biom...
- Vanderbilt-Ingram Cancer Center
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver MetastasesNCT00062348
Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionNCT00002901
Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerNCT00963326
Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI)
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or LarynxNCT00004227
Head and Neck C...
cetuximab
conventional su...
radiation thera...
18 Years - University of Alabama at Birmingham
Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00003328
Head and Neck C...
porfiromycin
radiation thera...
18 Years - National Cancer Institute (NCI)
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or TongueNCT00002735
Head and Neck C...
Induction chemo...
cisplatin
fluorouracil
low-LET cobalt-...
18 Years - 120 YearsSWOG Cancer Research Network
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckNCT00063895
Recurrent Non-s...
Recurrent Ovari...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IIIA Non-...
Stage IIIA Ovar...
Stage IIIB Non-...
Stage IIIB Ovar...
Stage IIIC Ovar...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
erlotinib hydro...
pharmacological...
pharmacogenomic...
laboratory biom...
18 Years - National Cancer Institute (NCI)
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryNCT00041171
Adult Solid Tum...
Breast Cancer
Head and Neck C...
Kidney and Urin...
Male Reproducti...
Thorax and Resp...
Hypericum perfo...
docetaxel
placebo
18 Years - 120 YearsAlliance for Clinical Trials in Oncology
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00410826
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
erlotinib hydro...
cisplatin
3-dimensional c...
intensity-modul...
quality-of-life...
18 Years - University of Washington
AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck CancerNCT00415298
Head and Neck C...
DACH polymer pl...
oxaliplatin
gene expression...
immunohistochem...
pharmacological...
biopsy
18 Years - National Cancer Institute (NCI)
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsNCT00089362
Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerNCT00897793
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00721513
Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 YearsWake Forest University Health Sciences
Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal CancerNCT01953952
Stage III Squam...
Stage IVA Squam...
Tongue Cancer
therapeutic con...
intensity-modul...
cisplatin
quality-of-life...
laboratory biom...
18 Years - Radiation Therapy Oncology Group
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerNCT00851877
Head and Neck C...
Cetuximab
Cisplatin
Nab-Paclitaxel
intensity-modul...
18 Years - 120 YearsUniversity of Texas Southwestern Medical Center
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
Docetaxel in Treating Patients With Solid TumorsNCT00003565
Bladder Cancer
Breast Cancer
Head and Neck C...
Lung Cancer
Unspecified Adu...
docetaxel
18 Years - Alliance for Clinical Trials in Oncology
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerNCT00003251
Drug/Agent Toxi...
Head and Neck C...
Radiation Toxic...
amifostine trih...
cisplatin
paclitaxel
radiation thera...
18 Years - National Cancer Institute (NCI)
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckNCT00079053
Head and Neck C...
erlotinib hydro...
adjuvant therap...
18 Years - 120 YearsCanadian Cancer Trials Group
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyNCT01728480
Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerNCT02177838
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerNCT00084435
Head and Neck C...
cisplatin
docetaxel
radiation thera...
18 Years - SWOG Cancer Research Network
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyNCT02123511
Mucositis
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Lympho...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Lymph...
Stage IVA Mucoe...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Lymph...
Stage IVB Mucoe...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Lymph...
Stage IVC Mucoe...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
acetylcysteine
placebo
quality-of-life...
questionnaire a...
18 Years - Mayo Clinic
Radiation Therapy in Treating Patients With Head and Neck CancerNCT00021125
Head and Neck C...
Non-melanomatou...
adjuvant therap...
radiation thera...
- National Cancer Institute (NCI)
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyNCT00898430
Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckNCT00720304
Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center
Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck CancerNCT00899821
Head and Neck C...
aldesleukin
recombinant int...
sargramostim
immunologic tec...
biopsy
20 Years - 80 YearsNYU Langone Health
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx CancerNCT01084083
Head and Neck C...
Precancerous Co...
cetuximab
intensity-modul...
Paclitaxel
Cisplatin
18 Years - Eastern Cooperative Oncology Group
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck CancerNCT00006033
Head and Neck C...
gene therapy
interleukin-2 g...
methotrexate
18 Years - National Cancer Institute (NCI)
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerNCT00003582
Carcinoma of Un...
Head and Neck C...
amifostine trih...
cisplatin
fluorouracil
paclitaxel
quality-of-life...
radiation thera...
18 Years - 120 YearsUniversity of Miami
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or LarynxNCT00004234
Head and Neck C...
Oral Complicati...
management of t...
radiation thera...
16 Years - 120 YearsCanadian Cancer Trials Group
Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer SurvivorsNCT01504932
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Tongue Cancer
BRB Lozenge
Survey Administ...
Laboratory Biom...
pharmacological...
21 Years - Ohio State University Comprehensive Cancer Center
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerNCT01313390
Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or LarynxNCT00004234
Head and Neck C...
Oral Complicati...
management of t...
radiation thera...
16 Years - 120 YearsCanadian Cancer Trials Group
Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerNCT00665392
Head and Neck C...
cisplatin
docetaxel
fluorouracil
Cetuximab
18 Years - 75 YearsGERCOR - Multidisciplinary Oncology Cooperative Group
Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00281840
Head and Neck C...
bevacizumab
docetaxel
conventional su...
radiation thera...
18 Years - Case Comprehensive Cancer Center
Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckNCT00083057
Head and Neck C...
gefitinib
paclitaxel
radiation thera...
18 Years - National Institutes of Health Clinical Center (CC)
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.NCT01469429
Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00049283
Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or ThroatNCT00017173
Head and Neck C...
Ad5CMV-p53 gene
cisplatin
conventional su...
radiation thera...
18 Years - SWOG Cancer Research Network
Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced XerostomiaNCT00081029
Head and Neck C...
Radiation Toxic...
Xerostomia
management of t...
radiation thera...
- National Cancer Institute (NCI)
Germline Mutations in Patients With Head and Neck Cancer and a Family History of CancerNCT00482872
Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 YearsVanderbilt University Medical Center
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive TractNCT00765440
Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 YearsCentre Antoine Lacassagne
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsNCT00006036
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 YearsCanadian Cancer Trials Group
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00721513
Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 YearsWake Forest University Health Sciences
Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During SurgeryNCT00002670
Head and Neck C...
chemotherapy
cisplatin
low-LET cobalt-...
low-LET electro...
low-LET photon ...
18 Years - Radiation Therapy Oncology Group
Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell CancerNCT00566540
Head and Neck C...
Cisplatin
Paclitaxel
Intensity-Modul...
Triple endoscop...
18 Years - Ohio State University Comprehensive Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00049283
Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerNCT01155609
Mucositis
Oral Complicati...
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
quality-of-life...
management of t...
L-lysine
18 Years - University of Washington
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: